Blood Pressure Drug Losartan Recalled Due to Contamination
All Locations•All Specialties
What you need to know
Drug maker Sandoz Inc. is recalling one lot of its Losartan Potassium Hydrochlorothiazide Tablets because the pills may have been contaminated with trace amounts of N-nitrosodiethylamine (NDEA), a known carcinogen. To date, no adverse events have been reported.
The following Losartan pills are affected:
- Losartan Potassium Hydrochlorothiazide
- 100 mg or 25 mg tablets in 1,000-count plastic bottles
- NDC: 0781-5207-10
- Lot number: JB8912
- Expiration date: 06/2020
- Distributed after October 8, 2018
For more information
Contact Sandoz Inc. at 1-800-525-8747 Monday-Friday 8:30 a.m. – 5:00 p.m. (EST).
